Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2V617F against myeloproliferative neoplasms

Min Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Tiantai Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Journal of Experimental & Clinical Cancer Research
February 4, 2019
Cited by 22


Related Papers